This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
New Frontiers in Neuroinflammation: What Happens When CNS and Periphery Meet?
joint with Advances in Neurodegenerative Disease Research and Therapy
Organizer(s): Marco Prinz, Jonathan Kipnis and Irene Knuesel
Date: June 17 - 21, 2018
Location: Keystone Resort, Keystone, CO, USA
Sponsored by Biogen, BioLegend, Inc., Genentech, Inc., Merck & Co., Inc., Nestlé Institute of Health Sciences, Roche and Takeda Pharmaceutical Company Limited
Summary of Meeting:
As the Greek name implies, glia are commonly known as the glue of the nervous system but, as non-neuronal cells, they essentially shape many key functions of the central nervous system (CNS). In contrast to other glial cells, microglia are more closely related to the peripheral immune system than to the neuroectoderm, making them unique within the CNS. Recent data suggest that brain-resident microglia are functionally distinct from the bone marrow-derived macrophages that invade the CNS under pathological conditions. During the last few years, the advent of novel tools in imaging, genetics and immunology, in particular high-throughput sequencing methods, has dramatically improved research of microglial biology. Recent studies, making use of these new methodologies, have yielded unexpected results that challenge the traditional view of microglia as simply scavengers of the diseased CNS. This conference will highlight the latest developments in the function of microglia for the CNS during health and disease.
Scholarship Deadline: February 15 2018
Discounted Abstract Deadline: February 15 2018
Abstract Deadline: March 15 2018
Discounted Registration Deadline: April 18 2018
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
BiogenBioLegend, Inc.Genentech, Inc.Merck & Co., Inc.Nestlé Institute of Health SciencesRocheTakeda Pharmaceutical Company Limited
We gratefully acknowledge additional support from these exhibitors at this conference:
The Paul G. Allen Frontiers Group
We gratefully acknowledge additional support for this conference from:
Abcam plcBio-Techne
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1R13NS106976-01
Funding for this conference was made possible (in part) by 1R13NS106976-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found